168 related articles for article (PubMed ID: 34426799)
1. Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity.
Nguyen H; Salkeld J; Agarwal S; Goodman A
Clin Infect Pract; 2021 Nov; 12():100089. PubMed ID: 34426799
[TBL] [Abstract][Full Text] [Related]
2. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy.
Taha Y; Wardle H; Evans AB; Hunter ER; Marr H; Osborne W; Bashton M; Smith D; Burton-Fanning S; Schmid ML; Duncan CJA
Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):85. PubMed ID: 34969393
[TBL] [Abstract][Full Text] [Related]
3. REGN-COV2 antibody cocktail in patients with SARS-CoV-2: Observational study from a single institution in Japan.
Sakurai A; Marshall S; Ogasawara T; Ogasawara T; Aoka Y; Sakura H; Uchigata Y; Ogawa T
J Infect Chemother; 2022 Jul; 28(7):943-947. PubMed ID: 35414436
[TBL] [Abstract][Full Text] [Related]
4. Duration of infectious viral shedding in patients with mild to moderate COVID-19 treated with REGN-CoV2.
Nomura T; Kitagawa H; Kakimoto M; Kaiki Y; Nazmul T; Miyamori D; Omori K; Shigemoto N; Ito M; Sakaguchi T; Ohge H
J Infect Chemother; 2022 Jul; 28(7):912-917. PubMed ID: 35370078
[TBL] [Abstract][Full Text] [Related]
5. Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals.
Kurshan A; Snell LB; Prior L; Tam JCH; Graham C; Thangarajah R; Edgeworth JD; Nebbia G; Doores KJ
Oxf Open Immunol; 2023; 4(1):iqac012. PubMed ID: 36844257
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of neutralizing antibody cocktail in hemodialysis patients: a case series of 20 patients treated with or without REGN-COV2.
Arikawa S; Fukuoka K; Nakamoto K; Kunitomo R; Matsuno Y; Shimazaki T; Saraya T; Kawakami T; Kishimoto M; Komagata Y; Kurai D; Ishi H; Kaname S
Clin Exp Nephrol; 2022 May; 26(5):476-485. PubMed ID: 35182277
[TBL] [Abstract][Full Text] [Related]
7. Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia.
Phan AT; Gukasyan J; Arabian S; Wang S; Neeki MM
Cureus; 2021 May; 13(5):e15280. PubMed ID: 34194882
[TBL] [Abstract][Full Text] [Related]
8. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
9. Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan.
Katsuo C; Kubota K; Tanaka K; Kurita Y; Nakajima A
Intern Med; 2023; 62(12):1765-1770. PubMed ID: 37316279
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effectiveness of REGN-COV2 in Patients with COVID-19 in Japan: A Retrospective Cohort Study with a Bayesian Inference.
Amano N; Iwata K; Iwata S
Infect Chemother; 2021 Dec; 53(4):767-775. PubMed ID: 34979607
[TBL] [Abstract][Full Text] [Related]
11. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
Soresina A; Moratto D; Chiarini M; Paolillo C; Baresi G; Focà E; Bezzi M; Baronio B; Giacomelli M; Badolato R
Pediatr Allergy Immunol; 2020 Jul; 31(5):565-569. PubMed ID: 32319118
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Course of COVID-19 Pneumonia in a 19-Year-Old Man on Intravenous Immunoglobulin Replacement Therapy for X-Linked Agammaglobulinemia.
Almontasheri A; Al-Husayni F; Alsuraihi AK; Binyahib H; Albanna AS
Am J Case Rep; 2021 Feb; 22():e929447. PubMed ID: 33612712
[TBL] [Abstract][Full Text] [Related]
13. Successful Treatment of Persistent Coronavirus Disease 2019 Infection in a Patient With Hypogammaglobulinemia With REGN-COV2: A Case Report.
Luitel P; Vais D; Gidron A
Open Forum Infect Dis; 2021 Aug; 8(8):ofab335. PubMed ID: 34405092
[TBL] [Abstract][Full Text] [Related]
14. Case report: Evolution of pulmonary manifestations and virological markers in critical COVID-19 infection in Bruton's agammaglobulinemia.
Rise N; Touborg T; Lundsted DH; Dalager-Pedersen M; Mogensen TH
Front Immunol; 2022; 13():1057065. PubMed ID: 36505407
[TBL] [Abstract][Full Text] [Related]
15. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.
Starr TN; Greaney AJ; Addetia A; Hannon WW; Choudhary MC; Dingens AS; Li JZ; Bloom JD
bioRxiv; 2020 Dec; ():. PubMed ID: 33299993
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
17. X-Linked Agammaglobulinemia and COVID-19: Two Case Reports and Review of Literature.
Devassikutty FM; Jain A; Edavazhippurath A; Joseph MC; Peedikayil MMT; Scaria V; Sandhya P; Govindaraj GM
Pediatr Allergy Immunol Pulmonol; 2021 Sep; 34(3):115-118. PubMed ID: 34495748
[No Abstract] [Full Text] [Related]
18. T Cell Abnormalities in X-Linked Agammaglobulinaemia: an Updated Review.
Chawla S; Jindal AK; Arora K; Tyagi R; Dhaliwal M; Rawat A
Clin Rev Allergy Immunol; 2023 Aug; 65(1):31-42. PubMed ID: 35708830
[TBL] [Abstract][Full Text] [Related]
19. Anti-SARS-CoV2 antibody-mediated cytokine release syndrome in a patient with acute promyelocytic leukemia.
Hegazy AN; Krönke J; Angermair S; Schwartz S; Weidinger C; Keller U; Treskatsch S; Siegmund B; Schneider T
BMC Infect Dis; 2022 Jun; 22(1):537. PubMed ID: 35692034
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]